Ajay K. Israni

OPTN/SRTR 2024 Annual Data Report: Deceased Organ Donation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: June 11, 2026

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 22, 2026

Corrigendum to OPTN/SRTR 2023 Annual Data Report: Introduction [American Journal of Transplantation. Volume 25, Issue 2, Supplement 1, February 2025, Pages S11-S21].

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: April 12, 2026

Cancer Risk in Solid Organ Transplant Recipients With a Pretransplant Cancer History.

Journal: JAMA oncology

Published: March 12, 2026

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 09, 2026

Toward Smarter Allocation by Rethinking Kidney Donor Profile Index.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: November 15, 2025

Population-level cancer trends among solid organ transplant recipients in the United States during 1995-2021.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 29, 2025

A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant Recipients.

Journal: Clinical pharmacokinetics

Published: September 11, 2025

Reply to "Real-world registry evidence beware: Old-world risk analysis may not be applicable to new world belatacept utilization".

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 12, 2025

OPTN/SRTR 2024 Annual Data Report: Deceased Organ Donation.

OPTN/SRTR 2024 Annual Data Report: Deceased Organ Donation.

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Corrigendum to OPTN/SRTR 2023 Annual Data Report: Introduction [American Journal of Transplantation. Volume 25, Issue 2, Supplement 1, February 2025, Pages S11-S21].

Corrigendum to OPTN/SRTR 2023 Annual Data Report: Introduction [American Journal of Transplantation. Volume 25, Issue 2, Supplement 1, February 2025, Pages S11-S21].

Cancer Risk in Solid Organ Transplant Recipients With a Pretransplant Cancer History.

Cancer Risk in Solid Organ Transplant Recipients With a Pretransplant Cancer History.

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Toward Smarter Allocation by Rethinking Kidney Donor Profile Index.

Toward Smarter Allocation by Rethinking Kidney Donor Profile Index.

Population-level cancer trends among solid organ transplant recipients in the United States during 1995-2021.

Population-level cancer trends among solid organ transplant recipients in the United States during 1995-2021.

A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant Recipients.

A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant Recipients.

Reply to "Real-world registry evidence beware: Old-world risk analysis may not be applicable to new world belatacept utilization".

Reply to "Real-world registry evidence beware: Old-world risk analysis may not be applicable to new world belatacept utilization".

Access to Transplant for African American and Latino Patients Under the 2014 US Kidney Allocation System.

Access to Transplant for African American and Latino Patients Under the 2014 US Kidney Allocation System.

OPTN/SRTR 2023 Annual Data Report: Introduction.

OPTN/SRTR 2023 Annual Data Report: Introduction.

OPTN/SRTR 2023 Annual Data Report: Heart.

OPTN/SRTR 2023 Annual Data Report: Heart.